Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RUPAFIN 10 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/RUPAFIN 10 MG COMPRIMIDOS

Approved

STANDARD

RUPAFIN 10 MG COMPRIMIDOS

Noucor Health S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 27, 2023
Approval ID: 5b75dba341cecfdd
Company: Noucor Health S.A.
Type: Standard

Approval Details

Approval Id: 5b75dba341cecfdd
Drug Cima Aemps Name: RUPAFIN 10 MG COMPRIMIDOS
Register Number: 3400938416220IP
Holder Company Name: Noucor Health S.A.
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/noucor-health-s-a
Authorization Date: 2023-04-27
Dosage Form: COMPRIMIDO
Dose: 10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Noucor Health S.A.
Company Detail Path: /organization/noucor-health-s-a

Company Information

Pharmaceutical Company Name: NOUCOR HEALTH S.A.
Country Name: Spain
City Name: barcelona,barcelona,country_es
Address: CALLE DEGA BAHI 59

Active Ingredients

RUPATADINA FUMARATO

12,8 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 27, 2023

Approval ID

5b75dba341cecfdd

Type

Standard

Back to CIMA-AEMPS Approvals